Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:contrastsWith |
gptkb:Schedule_III_(US)
gptkb:Schedule_V_(US) gptkb:Schedule_II_(US) Schedule IV (US) |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
No currently accepted medical use in treatment in the United States
High potential for abuse Lack of accepted safety for use under medical supervision |
| gptkbp:establishedBy |
gptkb:Controlled_Substances_Act_of_1970
|
| gptkbp:example |
gptkb:Heroin
gptkb:Marijuana gptkb:Methaqualone gptkb:Psilocybin gptkb:MDMA LSD |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule I (US)
|
| gptkbp:legalStatus |
Illegal to manufacture, distribute, or possess
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:regulates |
gptkb:Depressants
gptkb:Hallucinogens Narcotics Stimulants |
| gptkbp:bfsParent |
gptkb:LSD
|
| gptkbp:bfsLayer |
5
|